Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

for
Breast Cancer, Colorectal Cancer, Pancreas Cancer,
Location: Kingston, Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05403177

Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

for
Oncology, Breast Cancer, Prostate Cancer, Gynecologic Cancer,
Location: Toronto, Pittsburgh PA, Milwaukee WI, Houston TX
Sponsor: UMC Utrecht

Sex: All

Age: 18+

Code: NCT04075305

Recruiting

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Melanoma, Head and Neck Cancer,
Location: New Haven CT, New York NY, Baltimore MD, Rockville MD,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06172478

Phase 2, Recruiting

Artificial Intelligence in Endoscopic Ultrasound

for
Pancreatic Cancer, Pancreas Disease, Pancreatic Cyst
Location: Orlando FL
Sponsor: Orlando Health, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06564571

Recruiting

Genomic Investigation of Unusual Responders

for
Cancer, Breast Cancer, Non-small Cell Lung Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT03740503

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

for
Solid Tumors, Advanced Cancer, Renal Cancer, Gastric Cancer,
Location: Montreal, Hershey PA, Chapel Hill NC, Toronto,
Sponsor: Apollomics Inc.

Sex: All

Age: 18+

Code: NCT03175224

Phase 2, Recruiting

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

for
Invasive Ductal Breast Carcinoma,
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05837767

Recruiting
New

The Use of Contrast Enhanced Ultrasound (CEUS) In Post-Surgical Pancreatic Cancer Patients to Evaluate Local Disease Recurrence

for
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer,
Location: Philadelphia PA
Sponsor: Thomas Jefferson University

Sex: All

Age: 18+

Code: NCT07910383

Recruiting
New

Lm-LLO-TT and Gemcitabine in Unresectable Pancreatic Ductal Adenocarcinoma

for
Pancreas Cancer, Duct Cell Adenocarcinoma, Pancreatic Cancer,
Location: The Bronx NY
Sponsor: Loki Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07828236

Phase 1, Recruiting
New

Reach and Engagement of GENetic Education, Risk Assessment, and TEsting Feasibility Trial

for
Pancreatic Ductal Adenocarcinoma (PDAC),
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT07787156

Recruiting

A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer

for
Pancreatic Cancer, Metastatic,
Location: New York NY, Summit NJ, Maumee OH
Sponsor: Engeneic Pty Limited

Sex: All

Age: 18+

Code: NCT07049055

Phase 1, Phase 2, Recruiting

Pancreatic Cancer Early Detection Consortium

for
Pancreas Cancer, Pancreas Cyst,
Location: Boston MA, Worcester MA, New Haven CT, White Plains NY,
Sponsor: Arbor Research Collaborative for Health

Sex: All

Age: 18 - 70+

Code: NCT04970056

Recruiting

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

for
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer,
Location: Milwaukee WI, Seattle WA
Sponsor: Pancreatic Cancer Research Team

Sex: All

Age: 18+

Code: NCT03634332

Phase 2, Recruiting

PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

for
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma,
Location: New York NY
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT05737615

Phase 1, Recruiting

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

for
Localized Pancreatic Adenocarcinoma,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05518903

Phase 2, Recruiting

Targeted Pathway Inhibition in Patients With Pancreatic Cancer

for
Locally Advanced Pancreatic Ductal Adenocarcinoma,
Location: Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT04005690

Early Phase 1, Recruiting

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

for
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT06122896

Early Phase 1, Recruiting

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Ductal Adenocarcinoma,
Location: Lake Success NY, Miami FL, Detroit MI, Houston TX,
Sponsor: PanTher Therapeutics

Sex: All

Age: 18+

Code: NCT06673017

Phase 1, Recruiting

A Prospective Registry for Patients at High-Risk for Pancreatic Cancer

for
Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC,
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06151223

Recruiting

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

for
Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Neoplasm,
Location: Shiloh IL, St Louis MO, Creve Coeur MO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05687123

Phase 1, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial